Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | THPO | P40225 | 1/20 | 0.33 |
| ▸ | EGLN1 | Q9GZT9 | 3/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20689871 | 0.88 | EGLN1 (0.40) | ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL20689907 | 0.87 | ALDH1A1 (0.39) | ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL20689868 | 0.85 | MEN1 (0.39) | ALDH1A1CYP1A2CYP2C9CYP2C19MAPK1 | |
| SCHEMBL20689872 | 0.83 | ALDH1A1 (0.36) | ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL19654661 | 0.83 | ALDH1A1 (0.35) | ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL19654673 | 0.83 | CLK4 (0.33) | ALDH1A1HTTHSD17B10 | |
| SCHEMBL20689874 | 0.82 | ALDH1A1 (0.35) | ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL19654658 | 0.80 | EGLN1 (0.36) | ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL19654672 | 0.80 | HDAC4 (0.33) | — | |
| SCHEMBL20689869 | 0.80 | HTT (0.41) | ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11018306-B2 | Compound for thermally activated delayed fluorescence and organic electroluminescence device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-05-25 | — | — | US | disclosed |
| US-20190036034-A1 | COMPOUND FOR THERMALLY ACTIVATED DELAYED FLUORESCENCE AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11018306-B2 | Compound for thermally activated delayed fluorescence and organic electroluminescence device including the same | TRPA1, SLCO2A1, TMEM109 | ALDH1A1 81/4885CYP1A2 1396/4885CYP3A4 775/4885 |
| US-20190036034-A1 | COMPOUND FOR THERMALLY ACTIVATED DELAYED FLUORESCENCE AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | TRPA1, SLCO2A1, TMEM109 | ALDH1A1 81/4885CYP1A2 1396/4885CYP3A4 775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.